RAPID REVERSAL OF SUICIDAL DEPRESSION: COMPARATIVE EFFECTIVENESS OF ECT VS. KETAMINE OVER THE LIFESPAN (REAKT-SD)

Registry ID

111-2023

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CENTRE FOR ADDICTION AND MENTAL HEALTH

Start date

2025-02-28

Last update

2024-02-29

Conditions

• DEPRESSION
• SUICIDALITY

Related clinical trials

• UNDERSTANDING AND TREATING SUICIDAL IDEATION WITH KETAMINE: A DIFFUSION MAGNETIC RESONANCE IMAGING STUDY
• CLINICAL TRIAL PROTOCOL TITLE: EVALUATING THE ROLE OF PSILOCYBIN MONITORS IN PSILOCYBIN THERAPY FOR TREATMENT RESISTANT DEPRESSION: A PILOT RANDOMIZED CLINICAL TRIAL
• INTRAVENOUS KETAMINE AND IMMERSIVE VIRTUAL REALITY TO TREAT DEPRESSION (TREASURE TRIAL): A PILOT, RANDOMIZED CONTROLLED TRIAL
• ENGAGING MOOD BRAIN CIRCUITS WITH PSILOCYBIN: A RANDOMIZED NEUROIMAGING TRIAL IN DEPRESSION
• PSILOCYBIN-ASSISTED EXISTENTIAL, ATTACHMENT AND RELATIONAL (PEARL) THERAPY FOR CAREGIVERS OF PATIENTS WITH ADVANCED CANCER: A PHASE II OPEN-LABEL TRIAL
• A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ADJUNCTIVE D-CYCLOSERINE AND ACCELERATED INTERMITTENT THETA BURST STIMULATION FOR EMERGING ADULTS WITH SUICIDAL IDEATION

View on source registry